Cambridge Nutraceuticals Ltd   Report issue

For profit Phase 3
Founded: Cambridge United Kingdom (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

CamNutra Ltd.

Active Ingredients

Drugs in Phase 3 Trials (1)

prolycopene (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 3)

Heart Diseases (Phase 3)

Myocardial Ischemia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1